Kim M. Hemsley

2.1k total citations
79 papers, 1.7k citations indexed

About

Kim M. Hemsley is a scholar working on Physiology, Cell Biology and Epidemiology. According to data from OpenAlex, Kim M. Hemsley has authored 79 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Physiology, 21 papers in Cell Biology and 20 papers in Epidemiology. Recurrent topics in Kim M. Hemsley's work include Lysosomal Storage Disorders Research (56 papers), Cellular transport and secretion (19 papers) and Trypanosoma species research and implications (18 papers). Kim M. Hemsley is often cited by papers focused on Lysosomal Storage Disorders Research (56 papers), Cellular transport and secretion (19 papers) and Trypanosoma species research and implications (18 papers). Kim M. Hemsley collaborates with scholars based in Australia, New Zealand and France. Kim M. Hemsley's co-authors include John J. Hopwood, Adeline A. Lau, Barbara King, Sofia Hassiotis, Helen Beard, Allison C. Crawley, Jeremy D. Hopwood, Lauren S. Whyte, Ann D. Crocker and Timothy J. Sargeant and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and Neuroscience.

In The Last Decade

Kim M. Hemsley

73 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kim M. Hemsley Australia	25	1.2k	474	443	416	204	79	1.7k
Alessandro Simonati Italy	28	864 0.7×	562 1.2×	959 2.2×	218 0.5×	488 2.4×	94	2.2k
Mercè Pineda Spain	26	642 0.5×	175 0.4×	995 2.2×	208 0.5×	199 1.0×	54	2.0k
Bruno A. Benítez United States	26	926 0.7×	192 0.4×	767 1.7×	99 0.2×	371 1.8×	67	2.4k
Robert A. Durham United States	17	1.3k 1.0×	180 0.4×	772 1.7×	90 0.2×	373 1.8×	22	1.8k
Maria Kousi United States	12	374 0.3×	236 0.5×	621 1.4×	67 0.2×	173 0.8×	15	1.2k
Ana F. Nunes Portugal	19	403 0.3×	227 0.5×	583 1.3×	123 0.3×	310 1.5×	30	1.4k
Bart Dermaut Belgium	31	1.3k 1.1×	232 0.5×	1.9k 4.3×	104 0.3×	540 2.6×	64	3.3k
Taiji Tsunemi Japan	19	555 0.4×	333 0.7×	967 2.2×	438 1.1×	609 3.0×	49	1.9k
Gonzalo I. Cancino Canada	17	375 0.3×	95 0.2×	751 1.7×	91 0.2×	240 1.2×	31	1.5k
Benjamı́n Torrejón-Escribano Spain	17	439 0.4×	115 0.2×	449 1.0×	102 0.2×	264 1.3×	28	1.1k

Countries citing papers authored by Kim M. Hemsley

Since Specialization

Citations

This map shows the geographic impact of Kim M. Hemsley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim M. Hemsley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim M. Hemsley more than expected).

Fields of papers citing papers by Kim M. Hemsley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim M. Hemsley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim M. Hemsley. The network helps show where Kim M. Hemsley may publish in the future.

Co-authorship network of co-authors of Kim M. Hemsley

This figure shows the co-authorship network connecting the top 25 collaborators of Kim M. Hemsley. A scholar is included among the top collaborators of Kim M. Hemsley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim M. Hemsley. Kim M. Hemsley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Snel, Marten F., et al.. (2025). Multi-omics analyses of early-onset familial Alzheimer's disease and Sanfilippo syndrome zebrafish models reveal commonalities in disease mechanisms. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(3). 167651–167651.

Finnie, John, Kim M. Hemsley, Jim Manavis, et al.. (2024). Striking and widespread microglial activation in the brains of Southdown lambs with type II glucocerebrosidosis (neuronopathic Gaucher disease). Journal of Comparative Pathology. 215. 10–13.

Choo, Amanda, Dani L. Webber, Paul J. Trim, et al.. (2024). Drosophila melanogastermodels ofMPS IIIC(Hgsnat‐deficiency) highlight the role of glia in disease presentation. Journal of Inherited Metabolic Disease. 47(2). 340–354. 1 indexed citations

Lau, Adeline A., Helen Beard, Keliang Xie, et al.. (2024). Photobiomodulation in the infrared spectrum reverses the expansion of circulating natural killer cells and brain microglial activation in Sanfilippo mice. Journal of Neurochemistry. 168(9). 2791–2813. 1 indexed citations

Hemsley, Kim M., et al.. (2024). Application of diceCT to Study the Development of the Zika Virus-Infected Mouse Brain. Viruses. 16(8). 1330–1330.

Hemsley, Kim M., Helen Beard, Glyn Chidlow, et al.. (2023). Repetitive, non-invasive imaging of neurodegeneration, and prevention of it with gene replacement, in mice with Sanfilippo syndrome.. Experimental Neurology. 371. 114610–114610.

Winner, Leanne K., Mary‐Louise Rogers, Marten F. Snel, & Kim M. Hemsley. (2023). Biomarkers for predicting disease course in Sanfilippo syndrome: An urgent unmet need in childhood‐onset dementia. Journal of Neurochemistry. 166(3). 481–496. 7 indexed citations

Winner, Leanne K., Helen Beard, Litsa Karageorgos, et al.. (2023). The ovine Type II Gaucher disease model recapitulates aspects of human brain disease.. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(4). 166658–166658. 2 indexed citations

Beard, Helen, Glyn Chidlow, Daniel Neumann, et al.. (2020). Is the eye a window to the brain in Sanfilippo syndrome?. Acta Neuropathologica Communications. 8(1). 194–194. 5 indexed citations

10.

Whyte, Lauren S., Adeline A. Lau, Kim M. Hemsley, John J. Hopwood, & Timothy J. Sargeant. (2016). Endo‐lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?. Journal of Neurochemistry. 140(5). 703–717. 115 indexed citations

11.

King, Barbara, Sofia Hassiotis, Paul J. Trim, et al.. (2016). Slow, continuous enzyme replacement via spinal CSF in dogs with the paediatric‐onset neurodegenerative disease, MPS IIIA. Journal of Inherited Metabolic Disease. 40(3). 443–453. 14 indexed citations

12.

Beard, Helen, Amanda Luck, Sofia Hassiotis, et al.. (2015). Determination of the role of injection site on the efficacy of intra-CSF enzyme replacement therapy in MPS IIIA mice. Molecular Genetics and Metabolism. 115(1). 33–40. 26 indexed citations

13.

Hassiotis, Sofia, Barbara King, Tina Rozaklis, et al.. (2014). Delivery of therapeutic protein for prevention of neurodegenerative changes: Comparison of different CSF-delivery methods. Experimental Neurology. 263. 79–90. 23 indexed citations

14.

Keating, Damien J., Marnie Winter, Kim M. Hemsley, et al.. (2012). Exocytosis is impaired in mucopolysaccharidosis IIIA mouse chromaffin cells. Neuroscience. 227. 110–118. 15 indexed citations

15.

Jolly, R.D., et al.. (2010). Intracisternal enzyme replacement therapy in lysosomal storage diseases: routes of absorption into brain. Neuropathology and Applied Neurobiology. 37(4). 414–422. 20 indexed citations

16.

Hemsley, Kim M., Elizabeth J. Norman, Allison C. Crawley, et al.. (2009). Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs—A proof of principle study. Molecular Genetics and Metabolism. 98(4). 383–392. 48 indexed citations

17.

Hemsley, Kim M., Helen Beard, Barbara King, & John J. Hopwood. (2008). Effect of high dose, repeated intra‐cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice. Genes Brain & Behavior. 7(7). 740–753. 67 indexed citations

18.

Hemsley, Kim M., Barbara King, & John J. Hopwood. (2006). Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice. Molecular Genetics and Metabolism. 90(3). 313–328. 75 indexed citations

19.

King, Barbara, et al.. (2005). Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA. Molecular Genetics and Metabolism. 87(2). 107–112. 25 indexed citations

20.

Crocker, Ann D. & Kim M. Hemsley. (2001). An animal model of extrapyramidal side effects induced by antipsychotic drugs: relationship with D2 dopamine receptor occupancy. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 25(3). 573–590. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact